The Sumatriptan and Naratriptan Pregnancy Registry
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary) ; Naratriptan (Primary) ; Sumatriptan (Primary)
- Indications Migraine
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 14 Nov 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Nov 2011 Planned patient number is 1 according to ClinicalTrials.gov.
- 06 Feb 2010 New trial record